BELGRADE, Mont., May 04, 2016 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medical devices, today reported its financial results for the period ended March 31st, 2016. The Company reported quarterly revenues of approximately $21.0 million and an EBITDA loss of approximately $145,000. Revenue First quarter 2016 […]